一个大范围的审查:老年痴呆症患者的财务剥削
1Case Western Reserve University, Cleveland, OH, USA.
Trauma, violence & abuse
|October 30, 2025
概括
金融剥削 (FE) 是痴呆症患者的重大老年虐待风险. 需要更多的研究和多层次的战略来保护这个脆弱的人群免受FE的侵害.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 社会科学 社会科学 社会科学
背景情况:
- 财务剥削 (FE) 是一种普遍存在的虐待老年人的形式.
- 患有痴呆症的老年人由于认知能力下降和其他因素,特别容易患FE.
- 现有关于FE在这个人群中的研究是有限的,特别是在风险因素和干预措施方面.
研究的目的:
- 进行对老年痴呆症患者金融剥削的文献进行范围审查.
- 确定与FE相关的关键主题,风险因素,警告标志和干预策略.
- 在脆弱的老年人中提高FE的认识和知识.
主要方法:
- 按照阿克西和奥马利框架进行系统的范围审查.
- 搜索了四个数据库 (Ageline,Medline,CINAHL,PsycINFO) 的同行评审文章,截至2024年7月.
- 包括 21 篇文章 (14 篇定量, 7 篇定性) 用于数据提取和专题分析.
主要成果:
- 确定了七个关键主题:FE的流行,FE和认知功能之间的联系,病例描述,风险因素,警告标志,解决FE的策略,以及保护的障碍/促进者.
- 强调需要多层次战略 (个人,专业,机构,系统) 来打击FE.
- 发现研究多样化但分散,仅限于FE和痴呆症的交叉点.
结论:
- 强调需要综合方法来预防和解决痴呆症老年人FE的必要性.
- 强调未来需要对不良影响,政策制定 (例如,强制性报告) 和干预设计 (例如,护理人员教育) 的研究.
- 呼吁通过有针对性的干预和政策变革,加强对这一处于风险的人口群体的支持和保护.
相关概念视频
Dementia
508
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
508
Drug Dosing: Geriatric Patients
217
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
217
Pharmacodynamics in Geriatric Patients: Effects of Age
182
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
218
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
218
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
192
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
192
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


